Evaluation of weekly escalating doses of dichloromethotrexate in patients with hepatocellular carcinoma and other solid tumors
- 1 August 1982
- journal article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 8 (3) , 305-310
- https://doi.org/10.1007/bf00254055
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Further experience in treating patients with hepatocellular carcinoma in UgandaCancer, 1980
- Clinical and Laboratory Reevalution of DichloromethotrexatePublished by Springer Nature ,1980
- TREATMENT OF OSTEOGENIC-SARCOMA .1. EFFECT OF ADJUVANT HIGH-DOSE METHOTREXATE AFTER AMPUTATION1979
- Collateral Sensitivity Between Methylene Dimethane Sulfonate and Halogenated Methotrexate Derivatives in the Yoshida Sarcoma In Vivo and In Vitro23JNCI Journal of the National Cancer Institute, 1977
- Effect of surgical and chemotherapeutic treatment on alpha-fetoprotein levels in patients with hepatocellular carcinomaCancer, 1976
- Comparison of two dose schedules of dichloromethotrexate (NSC-29630) in lung cancer.1973
- Preliminary clinical trials of dichloromethotrexate (NSC-29630) in hepatocellular carcinoma.1972
- Clinical studies of dichloromethotrexate (NSC 29630)Clinical Pharmacology & Therapeutics, 1965
- PHYSIOLOGICAL DISPOSITION OF DICHLOROMETHOTREXATE-CL36 IN ANIMALS1962
- Prolongation of the Lifespan of Mice With Advanced Leukemia (L1210) by Treatment With Halogenated Derivatives of AmethopterinJNCI Journal of the National Cancer Institute, 1959